Human tumors are characterized by widespread reduction in microRNA (miRNA) expression, although it is unclear how such changes come about and whether they have an etiological role in the disease. Importantly, miRNA knockdown has been shown to enhance the tumorigenic potential of human lung adenocarcinoma cells. A defect in miRNA processing is one possible mechanism for global downregulation. To explore this possibility in more detail in vivo, we have manipulated Dicer1 gene dosage in a mouse model of retinoblastoma. We show that although monoallelic loss of Dicer1 does not affect normal retinal development, it dramatically accelerates tumor formation on a retinoblastoma-sensitized background. Importantly, these tumors retain one wild-type Dicer1 allele and exhibit only a partial decrease in miRNA processing. Accordingly, in silico analysis of human cancer genome data reveals frequent hemizygous, but not homozygous, deletions of DICER1. Strikingly, complete loss of Dicer1 function in mice did not accelerate retinoblastoma formation. miRNA profiling of these tumors identified members of the let-7 and miR-34 families as candidate tumor suppressors in retinoblastoma. We conclude that Dicer1 functions as a haploinsufficient tumor suppressor. This finding has implications for cancer etiology and cancer therapy.
A large body of evidence indicates that alterations in the expression of microRNAs (miRNAs) contribute to cancer pathologies.
1 miRNAs function as agents of the RNA interference pathway to silence their cognate coding target genes either by cleaving mRNA molecules or by inhibiting their translation. 2 By silencing tumor-suppressive and oncogenic mRNAs, miRNAs themselves can function as oncogenes or tumor suppressors, respectively. 3 The let-7 family, for instance, limits lung tumorigenesis through inhibition of several oncogenes including members of the Ras family or HMGA2. 4, 5 Initial efforts to link miRNAs with cancer were based on expression analyses in which tumors were compared with normal tissues. Such expression profiling analyses revealed the characteristic miRNA signatures of human cancers. 6 Surprisingly, they also highlighted an overall downregulation of mature miRNAs in several types of mouse and human cancers. 7 This observation raised two important questions: (i) one of causality -is there a causative link between global downregulation of miRNAs and cancer progression or is the downregulation a byproduct of tumor development? and (ii) one of mechanism -what are the molecular mechanisms and the genetic events underlying such widespread changes in tumors? The first question was addressed by RNAi targeting of factors involved in miRNA maturation, such as DICER1 and DROSHA, showing that global downregulation of miRNA processing increased the transforming properties of a lung adenocarcinoma cell line in in vitro culture assays and in xenograft experiments. 8 Widespread silencing of miRNA expression was proposed to be, at least partly, a consequence of Myc-mediated transcriptional repression; 9 however, the data also raised the possibility that DICER1 might be a target of genetic disruption in human cancers. Surprisingly, however, although reduced levels of DICER1 have been reported in tumors, 10, 11 no loss-of-function mutations in DICER1 have been reported to date. There have, however, been reports of truncating mutations in TARBP2, encoding an integral component of a DICER1-containing complex, in sporadic and hereditary carcinomas with microsatellite instability. 12 Frameshift mutations in TARBP2 diminished TRBP protein expression and caused a partial defect in the processing of miRNAs. Importantly, the TRBP impairment is associated with a partial destabilization of the DICER1 protein. These data raised the possibility that Dicer downregulation rather than its complete loss of function is selected for during tumorigenesis.
To directly address this question, we manipulated Dicer1 (referred hereafter as Dic) gene dosage in a mouse model of retinoblastoma. As germline inactivation of Dic in mice causes an early embryonic lethal phenotype, 13 we specifically inactivated Dic in retinoblasts by combining a conditional floxed allele of Dic 14 with the retinal Chx10Cre transgenic line. 15 We chose this genetic model system for two main reasons. First, Chx10Cre-mediated inactivation of one Dic allele decreases the production of mature miRNAs without affecting retinogenesis. 16 Second, the Chx10Cre mice have been used to create the first preclinical mouse model of retinoblastoma. 17, 18 Chx10Cre-mediated inactivation of the Retinoblastoma (Rb) gene leads to inappropriate exit from the cell cycle of retinal progenitor cells and a block in rod maturation. 19 These mice do not develop retinoblastoma as expression of another Rb family member, p107, increases in a compensatory manner. 18 However, on a p107-null background, retinal Rb inactivation (Chx10Cre; Rb lox/lox p107 À/À ) leads to the formation of early hyperproliferative lesions, 17 which are often referred to as retinomas. 20 Importantly, these lesions rarely go on to become aggressive and invasive tumors and only do so in older animals, suggesting that additional oncogenic lesions are required for full-blown tumorigenesis. For example, conditional inactivation of p53 in mice is one mechanism through which these lesions can progress into aggressive retinoblastoma. 17 Accordingly, amplification and overexpression of MDMX, a key negative regulator of p53, is a frequent event that is selected during human retinoblastoma formation.
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Results
We first confirmed that specific loss of one Dic allele in retinal progenitor cells does not affect normal retinal development. As expected, histological analysis of the retinae of several Chx10Cre; Dic lox/ þ mice at various stages of postnatal development did not reveal any morphological abnormalities ( Figure 1) . Strikingly, however, on the retinoblastomasensitized background, loss of one Dic allele dramatically accelerated tumor formation (Figure 2a ; Dic lox/ þ mice (data not shown).
We next examined the retinae histologically at postnatal days P35 and onwards. As previously described, 18 the retinal cytoarchitecture of Chx10Cre; Rb lox/lox p107 À/À ; Dic þ / þ at P35 is slightly disrupted because of the focal expansion of immature cells from the inner nuclear layer (INL) and their protrusion through the outer plexiform layer (OPL) (Figure 1c ). In addition, defects in the maturation of the rod photoreceptors lead to a hypocellular outer nuclear layer (ONL), although the three nuclear layers are still detected in these mice. In contrast, the three nuclear layers can no longer be distinguished in the Dic heterozygous mutants (Figure 2c This histopathological analysis indicated that the phenotype observed in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ retinae is similar in nature but is significantly more severe than that observed in Chx10Cre; Rb lox/lox p107 À/À retinae. We therefore hypothesized that the dysplasia and the partial degeneration observed in Dic heterozygous retinae might result from severe expansion of a pool of retinal progenitor cells that normally reside in the INL. Accordingly, immunostaining showed that the cells that disrupted synaptogenesis in the OPL and extended all the way to the apical surface of the retinae expressed the progenitor cell markers Syntaxin and Chx10 [25] [26] [27] ( Figure 3 ). The early tumors also stained for Calretinin, which labels a subset of amacrine and ganglion cells. However, Calretinin expression was less abundant than Syntaxin, more scattered and variable from animal to animal (data not shown). Calbindin, which labels horizontal cells and a subset of amacrine cells weakly, was either expressed at very low levels or undetectable in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ early lesions (data not shown). Together, these data indicate that the lesions are composed of retinal progenitor cells biased toward the amacrine cell fate. Importantly, these immature cells were GFP-positive and therefore Cre-positive ( Figure 3 ). Cre was fused to GFP in the Chx10Cre transgenic mice, 15 so that Cre-positive cells can be identified using anti-GFP antibodies. 
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As inappropriate expansion of the immature retinal cells could be a consequence of increased cell proliferation and/or survival, we measured cell proliferation and apoptosis using immunohistochemical assays. As previously reported, we found extensive BrdU incorporation in Chx10Cre; Rb lox/lox p107 À/À retinae at P14, a time when retinogenesis is normally complete. This phenotype was significantly exacerbated in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ retinae (Figure 4a and b) . Importantly, BrdU-positive cells were localized to the regions containing the GFP immunopositive cells and to where lamination was disrupted. These regions were also strongly positive for the proliferation marker Ki67 (Figure 4a and c) . BrdU-and Ki67-positive cells were found in all early dysplastic lesions and late (i.e., P200) retinoblastoma tumors (data not shown). Inappropriate cell proliferation leads to increased apoptosis in Chx10Cre; Rb lox/lox p107 À/À retinae. 17 Accordingly, active capase-3-positive cells could be detected in the Chx10Cre; Rb lox/lox p107 À/À retinae Figure 4 Proliferation and apoptosis in Chx10Cre; Rb lox/lox p107 ; Dic lox/ þ retinae. However, as the number of GFP-positive cells is increased in these retinae compared with the Chx10Cre; Rb lox/lox p107 À/À retinae, the data indicate that the number of dying Cre-positive cells is reduced proportionally in the Dicer1 heterozygous retinae (Figure 4d and e) .
Collectively, these data indicate that heterozygosity for a Dicer1 mutation promotes the switch from benign retinoma lesions to aggressive and invasive retinoblastomas. Monoallelic loss of Dic is sufficient to promote the expansion of retinal progenitor cells (with a bias toward the amacrine cell fate), which ultimately leads to the formation of early neoplastic lesions that progress into aggressive and metastatic tumors. The ability of these progenitor cells to form these aggressive tumors seems to be a consequence of both increased cell proliferation potential and resistance to apoptosis.
These data strongly support the view that Dicer1 functions in vivo as a haploinsufficient tumor suppressor gene. Considering that the dysplastic lesions in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ retinae are observed as early as P35, it is very unlikely that active selection against complete loss of the remaining wild-type Dic allele is required for tumorigenesis. However, this possibility had to be formally excluded experimentally. As expected, we obtained evidence of Cre-mediated recombination of the conditional Dic allele in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ normal retinae (Ctr Retinae, P20) and isolated tumors (Figure 5a and b) . Importantly, the wild-type allele was retained in all tumors carefully dissected and genotyped (Figure 5b ). To ensure that (Figure 5c, left panel) . Importantly, all mature miRNAs that are expressed at high levels in Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/ þ P20 retinae are expressed at comparable levels in all five tumors (Figure 5c, right panels) . These analyses indicate that microRNA processing is only partly impaired, but not completely disrupted, in these tumors. Finally, we directly assessed the consequences of complete Dicer1 inactivation in the retinoblastoma mouse model. We confirmed that complete ablation of Dicer1 in the retina is well tolerated and only leads to progressive retinal degeneration. 16 Similar results were obtained on the retinoblastoma-sensitized background. The retinae of adult Chx10Cre; Rb lox/lox p107 À/À ; Dic lox/lox were partly dis-organized (Lambertz et al., manuscript in preparation). Surprisingly, these mice were protected from tumor formation Figure 2a) . Together, the data argue that although partial loss of Dicer function favors tumor formation, complete loss of Dicer is deleterious to retinoblastoma development, further arguing in favor of a haploinsufficient tumor suppressor function of Dicer1.
These data also imply that a set of miRNAs, the function of which requires Dicer1 function, might act to prevent full-blown retinoblastoma formation on the Chx10Cre; Rb À/À ; Dic lox/ þ using LNA-based microarray and RT-qPCR approaches. Both types of analyses identified a common set of 11 miRNAs that are consistently upregulated between wild-type and Chx10Cre; Rb lox/lox p107 Figure 6a ). Most interestingly, among them are two members of the let-7 family (let-7c and let7i), the upregulation of which and of another let-7 member, let-7b, was confirmed by independent Q-RT-PCR analysis (Figure 6b ). Given that this upregulation was significantly attenuated in the Dic heterozygous retinae and the recognized role of let-7 family members in tumor suppression, 28 this observation raises the possibility that let-7 family members have a causal role in retinoblastoma formation as critical regulators of the switch from retinomas to retinoblastoma. Our list of 11 differentially expressed miRNAs also included miR-34c (Figure 6a and b) . There was also a clear upregulation of miR-34b-3p in both microarray and RT-q-PCR analyses, and a moderate, but reproducible, upregulation of miR-34a was evident from the microarray data (data not shown). Interestingly, the miR-34 family members have been identified as p53 targets and key mediators of its tumor suppressor function. 29 
Discussion
To address the importance of Dicer1 gene dosage in cancer development, we used a preclinical mouse model of retinoblastoma. 17 Our data provide clear genetic evidence that Dicer1 functions as a haploinsufficient tumor suppressor in vivo. In keeping with this observation, information in the public domain, for example, Cancer Genome Project at the Sanger Institute, 30 indicates that hemizygous deletions of DICER1 occur in 27% (207/761) of tumors derived from tissues of diverse origins, such as the central nervous system, lung, pancreas, soft tissues, breast, bone, hematopoietic or lymphoid. Importantly, consistent with our findings, homozygous deletions have never been observed in any of these 761 tumors. Very recently, heterozygous point mutations in DICER1 were reported in patients with pleuropulmonary blastoma. 31 However, DICER1 expression was retained in the mesenchymal tumor cells from these patients, again arguing against strong selective pressure for complete loss of Dicer function in human tumors. Thus, although this study focuses on the role of Dicer1 in a mouse model of retinoblastoma, there is evidence supporting a broad role for DICER1 as a haploinsufficient tumor suppressor in human cancer.
Kumar et al. had attempted to investigate an etiological role for Dicer1 in a mouse model of cancer, in which Dicer1 was inactivated in a K-Ras-induced mouse model of lung cancer using intranasal infection with adenovirus expressing Cre. 8 Although it highlighted an important role for Dicer1 in tumor suppression, this elegant study did not resolve the important issue of gene dosage. The authors had shown that tumorigenesis was enhanced on both Dic lox/ þ and Dic loxlox genetic backgrounds, but they did not analyze the extent of Cre-mediated Dicer1 inactivation in these tumors. It therefore remained formally possible that lung tumors developed in the Dic loxlox mice only as a result of incomplete inactivation of Dicer1 function. This possibility has just very recently been confirmed in a study that was published while our manuscript was being processed. 32 This last report, together with the data presented herein, clearly emphasizes that only partial, rather than complete, inactivation of Dicer1 enhances tumorigenesis in vivo (Figure 7) .
It is generally accepted that complete loss of tumor suppressor function through mutations and loss of heterozygosity is a prerequisite for tumor development. To date, however, several haploinsufficient tumor suppressor genes have been identified, 33 mostly through the use of genetically engineered mouse models. Our mouse genetic data identify DICER1 as yet another member of this group. A general theme in haploinsufficient genes is that tumors generated in a haploinsufficient context are frequently of later onset and less severe than the corresponding tumor carrying the homozygously mutated gene. This is not the case for Dicer1. Complete loss of Dicer1 did not enhance but rather inhibited retinoblastoma formation. In agreement with this, biallelic loss of Dicer1 was strongly selected against in K-Ras-induced lung tumors. 32 To our knowledge, Dicer1 is therefore the first example of a gene that functions as a tumor suppressor only in the context of haploinsufficiency and not on homozygous loss of function. Regardless, as the list of haploinsufficient tumor suppressors grows, hemizygous deletions at loci such as DICER1 should be considered as potential key pro-tumorigenic lesions.
Our data further establish a causative link between global downregulation of miRNA-processing and cancer development. It is possible that the reduction of expression of only a subset of tumor suppressor miRNAs is the event that promotes tumorigenesis (Figure 7 ). In the context of retinoblastoma, our profiling data identified the let-7 family members as potential candidate tumor suppressors. It may be noted that let-7b has previously been shown to be downregulated in human retinoblastoma. 34 Other sets of miRNAs that can account for the observed tumor-suppressive activity of Dicer1 in retinoblastoma are the miR-34 family members. Given that these genes have been identified as p53 targets and are critical mediators of its activity 29 and the importance of the p53 tumor suppressor function in retinoblastoma, 17, 21 it will be interesting to further assess genetically their functional relevance in the retinoblastoma mouse model. It has been shown that miR-34 family members are differentially expressed in human retinoblastoma cell lines and tumors compared with normal retina samples. 35 Exogenous miR-34a inhibited cell growth and/or increased apoptosis in retinoblastoma cell lines (Y79, Weri-Rb1). 35 Together, these data identify the miR-34 family members as potential therapeutic targets for retinoblastoma. Interestingly, among the common putative mRNA targets of both let-7 and miR-34 family members is the N-myc oncogene. N-myc is indeed a validated miR-34a target (http://mirecords.umn.edu/miRecords/) and is a predicted target of let-7i (http://www.targetscan.org/). This gene is amplified in another mouse model of retinoblastoma 36 and in approximately 10% of human retinoblastomas. 37 These observations raise the possibility that members of both let-7 and miR34 families cooperate to restrain N-Myc oncogenic function in retinoblastoma.
Finally and importantly, our data argue against the development of DICER1-inactivating molecules as anticancer drugs. Indeed, even if complete Dicer1 inactivation seems to ; Dic lox/ þ P20 retinae (black, dKO; Dic lox/ þ ). (b) Expression analysis by RT-qPCR of let-7 family members (let-7b, let-7c and let-7i) and miR-34c be deleterious for cancer development its partial inactivation promotes, rather than inhibits, tumor formation.
Materials and Methods
Mice. All animal experiments were performed in accordance with the guidelines of the University of Ghent Animal Care and Use Ethics Committee. BrdU (100 mg/g of body weight) was injected intraperitoneally 1 h before killing. microRNA expression analyses. Total RNA was prepared from dissected retinae or isolated tumors using the miRNeasy kit (Qiagen) according to the manufacturer's instructions. Profiling of these samples was performed by both microarray (miRCURY LNA Array, Exiqon, Vedbaek, Denmark) and qPCR. The RTqPCR expression profiling of 522 murine miRNAs and subsequent data normalization were performed as described previously. 38, 39 Differential miRNA expression was evaluated using Student's t-test. Hierarchical clustering was performed using Ward's method and Manhattan distance using R Bioconductor software (Oxford, UK).
